Reuters: Supreme Court To Decide Generic Drug Labeling Issue
Reuters: Supreme Court To Decide Generic Drug Labeling IssueThe Supreme Court said on Friday that it would decide whether generic drug companies could be sued under state law over allegations they failed to provide adequate label warnings about potential side effects (Vicini, 12/11). This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.